Is it ethical to try and patent a gene?

Should genetic research be protected using intellectual property (IP) laws or does this approach stifle scientific collaboration and add costs? After more than a decade’s experience in the field discussing and arguing about this topic, I have concluded that there is a middle way between protection and openness. There can be no doubt that wrapping up research in an envelope of IP exclusivity can be particularly disadvantageous to developing and underdeveloped countries. New models have therefore emerged and will continue to evolve over the years. See full Article.